Cargando…

Assessment of the Safety and Therapeutic Benefits of Convalescent Plasma in COVID-19 Treatment: A Systematic Review and Meta-Analysis

Background: The coronavirus disease (COVID-19), caused by the Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), prompted a global health crisis, with no available specific treatments. Convalescent plasma (CP) with neutralizing antibodies could be a promising therapeutic approach to reduc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barreira, Daniela Ferreira, Lourenço, Rita Adubeiro, Calisto, Rita, Moreira-Gonçalves, Daniel, Santos, Lúcio Lara, Videira, Paula Alexandra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8055850/ https://www.ncbi.nlm.nih.gov/pubmed/33889590 http://dx.doi.org/10.3389/fmed.2021.660688

Ejemplares similares

Convalescent plasma trial shows no benefit
por: Brown, Matthew
Publicado: (2020)

Revisiting the clinical usefulness of C-reactive protein in the set of cancer cachexia
por: Tavares, Patrícia, et al.
Publicado: (2021)

High-titre convalescent plasma therapy for an immunocompromised patient with systemic lupus erythematosus with protracted SARS-CoV-2 infection
por: Moutinho-Pereira, Sara, et al.
Publicado: (2021)

Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy
por: Herman, Jonathan D., et al.
Publicado: (2022)

Potential benefit of convalescent plasma transfusions in immunocompromised patients with COVID-19
por: Rodionov, Roman N, et al.
Publicado: (2021)

Potential benefits, mechanisms, and uncertainties of convalescent plasma therapy for COVID-19
por: Dai, Weiqian, et al.
Publicado: (2020)

COVID-19 Pandemic and the Convalescent Plasma Therapy: Possible Benefits and Risks
por: Noor, Rashed, et al.
Publicado: (2021)

Sialyl Lewis(X/A) and Cytokeratin Crosstalk in Triple Negative Breast Cancer
por: Pascoal, Carlota, et al.
Publicado: (2023)

Convalescent plasma to deliver therapeutic antibodies against COVID-19
por: Senefeld, Jonathon W., et al.
Publicado: (2022)

Mortality Benefit of Convalescent Plasma in COVID-19: A Systematic Review and Meta-Analysis
por: Bansal, Vikas, et al.
Publicado: (2021)

COVID-19 convalescent plasma therapy for immunodeficient patients–weighing up risks and benefits
por: Vuk, T., et al.
Publicado: (2021)

Risk–benefit analysis on the clinical significance of convalescent plasma therapy in the management of COVID-19
por: Dhanasekaran, Sivaraman, et al.
Publicado: (2020)

Exercise Training Impacts Cardiac Mitochondrial Proteome Remodeling in Murine Urothelial Carcinoma
por: Ferreira, Rita, et al.
Publicado: (2018)

Chemotherapy-Induced Molecular Changes in Skeletal Muscle
por: Pedrosa, Mafalda Barbosa, et al.
Publicado: (2023)

Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Farag, Youssef M.K.
Publicado: (2020)

Safety and Efficacy of Convalescent Plasma in COVID-19: An Overview of Systematic Reviews
por: Franchini, Massimo, et al.
Publicado: (2021)

The importance of determining the amount of ‘therapeutic units’ before using convalescent plasma
por: Vieira, Yasmine Rangel, et al.
Publicado: (2021)

Dicoumarol: from chemistry to antitumor benefits
por: Silva, Vera L. M., et al.
Publicado: (2022)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Assessment of serological assays for identifying high titer convalescent plasma
por: Farnsworth, Christopher W., et al.
Publicado: (2021)

Earlier the better: convalescent plasma
por: Tobian, Aaron A.R., et al.
Publicado: (2020)

The resurgence of convalescent plasma therapy
por: The Lancet Haematology
Publicado: (2020)

COVID-19 convalescent plasma
por: Tobian, Aaron A. R., et al.
Publicado: (2022)

Development and Validation of a Treatment Benefit Index to Identify Hospitalized Patients With COVID-19 Who May Benefit From Convalescent Plasma
por: Park, Hyung, et al.
Publicado: (2022)

Therapeutic plasma exchange followed by convalescent plasma transfusion in critical COVID-19—An exploratory study
por: Jaiswal, Vinod, et al.
Publicado: (2021)

Get rid of the bad first: Therapeutic plasma exchange with convalescent plasma for severe COVID-19
por: Kesici, Selman, et al.
Publicado: (2020)

In Reply — Limitations of Safety Update on Convalescent Plasma Transfusion in COVID-19 Patients
por: Joyner, Michael. J., et al.
Publicado: (2020)

Safety Update: COVID-19 Convalescent Plasma in 20,000 Hospitalized Patients
por: Joyner, Michael J., et al.
Publicado: (2020)

Safety and Efficacy of Convalescent Plasma in Elderly COVID-19 Patients: The RESCUE Trial
por: Franchini, Massimo, et al.
Publicado: (2021)

Therapeutic Notes upon Convalescence
Publicado: (1887)

Concerted Regulation of Glycosylation Factors Sustains Tissue Identity and Function
por: Sobral, Daniel, et al.
Publicado: (2022)

Convalescent plasma to treat COVID-19
por: Bloch, Evan M.
Publicado: (2020)

Convalescent plasma for patients with COVID-19
por: Zeng, Furong, et al.
Publicado: (2020)

Convalescent plasma for COVID-19 considerations
por: Adiwinata Pawitan, Jeanne
Publicado: (2021)

Serosurveys and convalescent plasma in COVID-19
por: Pérez-Cameo, Cristina, et al.
Publicado: (2020)

COVID-19 convalescent plasma transfusion
por: Langhi, Dante Mário, et al.
Publicado: (2020)

Convalescent plasma in outpatients with COVID-19
por: Focosi, Daniele, et al.
Publicado: (2022)

Convalescent plasma: Alternative or promising therapy?
por: Mina, Fahmida Begum, et al.
Publicado: (2021)

BRCA1 VUS: A functional analysis to differentiate pathogenic from benign variants identified in clinical diagnostic panels for breast cancer
por: Lourenço, Rita Adubeiro, et al.
Publicado: (2023)

Efficacy and Safety of Convalescent Plasma for COVID-19: A Systematic Review and Meta-analysis
por: Prasad, Manya, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3hmujr5u6c6fv6dqv5ce4cfb6f